Global Cancer Diagnostics Market is expected to grow at a CAGR of 11.7% : Dominating with growing ageing population worldwide, government initiatives for funding and awareness about cancer

Global cancer diagnostics is expected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the growth of this market are the growing ageing population worldwide, government initiatives for funding and awareness about cancer. These factors increase the demand for cancer diagnostic products. On the other hand, stringent regulations imposed by international and local authorities and shortage of skilled and trained professionals may hinder the growth of the market.

Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market

Market Segmentation:

The global cancer diagnostics market is segmented on the basis of technology, application and geography. The global cancer diagnostics market is segmented into 2 types, namely platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 68.8% and is expected to continue this trend till 2024.

Cancer diagnostics platform based market is segmented into Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography- Computed Tomography (PET-CT), mammography and ultrasound.

On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Key Drivers:

Some of the major factors driving the market for cancer diagnostics market are growing ageing population worldwide, government initiatives for funding and awareness about cancer. These factors increase the demand for cancer diagnostics products. Increasing prevalence of cancer, key players focusing are on strategic decisions and technological advancements are the major factors driving the growth of the cancer diagnostics market.

• Stringent regulations imposed by the international and local authorities and shortage of the skilled and trained professionals are the factors which may hinder the growth of this market.

• Many companies are increasingly focusing on Next Generation Sequencing (NGS) and biopsy products in order to strengthen their product portfolios in the cancer diagnostics market.

• Increasing demand for Magnetic Resonance Imaging (MRI) and Next Generation Sequencing (NGS) will drive the market in future.

Key Points:

GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with Siemens Healthcare GmbH along with others such as Hologic, Inc, Becton, Dickinson & Company. Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as Roche Diagnostics, Abbott Laboratories, Inc. Qiagen.

• Next Generation Sequencing (NGS) market is growing with the highest CAGR.

• Globally biopsy is driving the market with highest market share.

• Magnetic Resonance Imaging(MRI) is dominating the cancer diagnostics imaging market.

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-diagnostics-market

TABLE OF CONTENTS

1. INTRODUCTION
1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL CANCER DIAGNOSTICS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED

2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES

4. PREMIUM INSIGHTS

5. EXECUTIVE SUMMARY

6. GLOBAL CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.2. PLATFORM BASED
6.3. INSTRUMENT BASED

7. GLOBAL CANCER DIAGNOSTICS MARKET, BY APPLICATION
7.1. OVERVIEW
7.2. LUNG CANCER
7.3. BREAST CANCER
7.4. COLORECTAL CANCER
7.5. MELANOMA
7.6. OTHERS

8. GLOBAL CANCER DIAGNOSTICS MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.2. NORTH AMERICA CANCER DIAGNOSTICS MARKET

For TOC or Buy Full Report, Visit: http://databridgemarketresearch.com/reports/global-cancer-diagnostics-market/

About Us
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. For Customization and Getting Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us
Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.